The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial-Reference-Cited by-同舟云学术

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

Published:2011-02 Issue:2 Volume:54 Page:219-226
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Huang Jee-Fu,Yu Ming-Lung,Huang Chung-Feng,Chiu Chang-Fu,Dai Chia-Yen,Huang Ching-I.,Yeh Ming-Lun,Yang Jeng-Fu,Hsieh Ming-Yen,Hou Nai-Jen,Lin Zu-Yau,Chen Shinn-Cherng,Wang Liang-Yen,Chuang Wan-Long

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. New hepatitis C guidelines for the Asia–Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection;Farrell;J Gastroenterol Hepatol,2007

2. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

3. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

4. Long-term effects of interferon-based therapy for chronic hepatitis C;Yu;Oncology,2007

5. Hepatitis C virus infection;Lauer;N Engl J Med,2001

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the era of direct-acting antivirals for hepatitis C in patients with unresectable hepatocellular carcinoma;Digestive Diseases;2021-11-09

2. Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication;Clinical Infectious Diseases;2019-11-28

3. Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?;Clinical and Molecular Hepatology;2019-06-25

4. Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study;BMJ Open;2019-05

5. Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?;Expert Review of Anti-infective Therapy;2018-11-09